Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Entheseal lesions, bone density linked with incident PsA in psoriasis patients
Key clinical point: Measures of structural entheseal lesions and entheseal bone mineral density using high-resolution peripheral quantitative CT was associated with incident psoriatic arthritis in patients with psoriasis.
Major finding: Psoriasis patients with at least one structural entheseal lesion had a 400% higher PsA incidence, compared with patients without lesions.
Study details: A single-center study of 114 patients with psoriasis followed for an average of 28 months.
Disclosures: Dr. Simon has been a consultant to AbbVie and Eli Lilly, a speaker on behalf of Eli Lilly, Janssen, and Novartis, and research funding from Eli Lilly and Novartis. Dr. McInnes has been a consultant to AbbVie, Bristol-Myers Squibb, Celgene, Eli Lilly, Gilead, Janssen, Novartis, Pfizer, and UCB, and he has received research funding from Bristol-Myers Squibb, Celgene, Eli Lilly, Janssen, and UCB.
Simon D et al. Ann Rheum Dis. 2020 Jun;79[suppl 1]:33-4, Abstract OP0051.